Intranasal formulation

Details Intranasal formulation Intranasal formulation

A - Human Necessities

61

K

167/237

A61K 31/415 (2006.01) A61K 9/00 (2006.01)

Patent

CA 1178889

Abstract Intranasal formulations for antiviral benz- imidazole compounds are disclosed. The formulations contain the active ingredient; a non-ionic, surface- active agent with a HLB number from 12 to 16; and a propellant.

384071

Affiliated with

Also associated with

Rating

Intranasal formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasal formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1171418